Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Vrtn (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 4,4'-sulfonyldiphenol | increases expression | ISO | Vrtn (Mus musculus) | 6480464 | bisphenol S results in increased expression of VRTN mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Vrtn (Mus musculus) | 6480464 | bisphenol S results in increased methylation of VRTN promoter | CTD | PMID:33297965 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of VRTN exon | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of VRTN mRNA | CTD | PMID:21934132 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of VRTN 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | Vrtn (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of VRTN exon | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of VRTN promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of VRTN protein | CTD | PMID:31163220 | bisphenol A | decreases expression | ISO | Vrtn (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of VRTN mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of VRTN protein | CTD | PMID:37567409 | bisphenol A | increases expression | ISO | Vrtn (Mus musculus) | 6480464 | bisphenol A results in increased expression of VRTN mRNA | CTD | PMID:30951980 | bisphenol F | increases expression | ISO | Vrtn (Mus musculus) | 6480464 | bisphenol F results in increased expression of VRTN mRNA | CTD | PMID:30951980 | cyclosporin A | decreases methylation | EXP | | 6480464 | Cyclosporine results in decreased methylation of VRTN promoter | CTD | PMID:27989131 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VRTN mRNA | CTD | PMID:27188386 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of VRTN mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VRTN mRNA | CTD | PMID:27188386 | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of VRTN protein | CTD | PMID:32959892 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of VRTN mRNA | CTD | PMID:19710929 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VRTN mRNA | CTD | PMID:27188386 | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of VRTN mRNA | CTD | PMID:30510588 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of VRTN mRNA | CTD | PMID:24935251 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of VRTN mRNA | CTD | PMID:25979313 | |